Childhood PFAS exposure and immunotoxicity: a systematic review and meta-analysis of human studies

Evangelia E Antoniou1, Wolfgang Dekant2

  • 1Epicurus-Reviews, MetaAnalyses.Com, Heesstraat 80, Bilzen, Belgium. e.antoniou@epicurus-reviews.com.

Systematic Reviews
|July 9, 2024
PubMed

Insights

Exposure to poly- and perfluoroalkyl substances (PFAS) may weaken infant and child immunity. This review found suggestive evidence linking PFAS to infections but limited evidence for reduced vaccine antibody responses.

Area of Science:

  • Environmental Health
  • Immunology
  • Pediatrics

Background:

  • Poly- and perfluoroalkyl substances (PFAS) are environmental contaminants linked to potential immunosuppression in infants and children.
  • Existing epidemiological data on PFAS exposure, vaccine response, and infection risk in children are inconclusive.
  • This systematic review addresses the need for a comprehensive summary of PFAS effects on pediatric immune health.

Purpose of the Study:

  • To systematically review and synthesize human studies on the association between prenatal/childhood PFAS exposure and vaccine antibody response.
  • To examine the relationship between PFAS exposure and the incidence of infectious diseases in children.
  • To assess the overall impact of PFAS on infant and childhood immune system function.

Main Methods:

  • A systematic literature search of MEDLINE/Pubmed was conducted for human studies published up to February 1, 2023.
  • Included studies were epidemiological, analyzing gestational or childhood PFAS exposure against pediatric vaccine antibody levels or infectious disease occurrence.
  • Data on exposure levels, timing, and outcomes were extracted, and meta-analyses were performed to calculate effect sizes.

Main Results:

  • Seventeen articles met the inclusion criteria for the meta-analysis.
  • A slight decrease in antibody response was generally observed with PFAS exposure.
  • Associations between PFAS exposure and increased childhood infections were noted.

Conclusions:

  • PFAS exposure may impact infant and childhood immune health, particularly concerning infections.
  • Suggestive evidence links specific PFAS (PFOS, PFOA, PFHxS, PFNA) to increased infection risk.
  • Evidence for PFAS-induced reduction in antibody titers is moderate to limited.
Abstract